Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial Cancer. | Biomed Res Int | 2022 | 35774278 | PubTator, text mining | PubMed |
| First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors. | Invest New Drugs | 2022 | 35767205 | PubTator, text mining | PubMed |
| Extracellular Matrix Stiffness in Lung Health and Disease. | Compr Physiol | 2022 | 35766837 | PubTator, text mining | PubMed |
| Hepatoid prostatic carcinoma with adrenal metastasis and novel genetic alterations. | Diagn Cytopathol | 2022 | 35765767 | PubTator, text mining | PubMed |
| Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification. | Mol Med | 2022 | 35764936 | PubTator, text mining | PubMed |
| The dynamic roles of the bladder tumour microenvironment. | Nat Rev Urol | 2022 | 35764795 | PubTator, text mining | PubMed |
| Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis. | J Cancer Res Clin Oncol | 2022 | 35761108 | PubTator, text mining | PubMed |
| Clioquinol as an inhibitor of JmjC-histone demethylase exhibits common and unique histone methylome and transcriptome between clioquinol and hypoxia. | iScience | 2022 | 35754713 | PubTator, text mining | PubMed |
| The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis. | Br J Pharmacol | 2022 | 35751904 | PubTator, text mining | PubMed |
| A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting. | Cancers (Basel) | 2022 | 35740637 | PubTator, text mining | PubMed |
| Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival. | Clin Lung Cancer | 2022 | 35739016 | PubTator, text mining | PubMed |
| Incidental discovery of acute myeloid leukemia during liquid biopsy of a lung cancer patient. | Cold Spring Harb Mol Case Stud | 2022 | 35732498 | PubTator, text mining | PubMed |
| English Long and Short Sentence Translation and Recognition Method Based on Deep GLR Model. | Comput Intell Neurosci | 2022 | 35720940 | PubTator, text mining | PubMed |
| The Zebrafish model in dermatology: an update for clinicians. | Discov Oncol | 2022 | 35713744 | PubTator, text mining | PubMed |
| Biophysics Role and Biomimetic Culture Systems of ECM Stiffness in Cancer EMT. | Glob Chall | 2022 | 35712024 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer. | Breast J | 2022 | 35711892 | PubTator, text mining | PubMed |
| Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. | Genomics | 2022 | 35709927 | PubTator, text mining | PubMed |
| Mechanisms during Osteogenic Differentiation in Human Dental Follicle Cells. | Int J Mol Sci | 2022 | 35682637 | PubTator, text mining | PubMed |
| Evaluation of in vitro fibroblast migration by electrospun triple-layered PU-CA/gelatin.PRGF/PU-CA scaffold using an AAVS1 targeted EGFP reporter cell line. | Bioimpacts | 2022 | 35677672 | PubTator, text mining | PubMed |
| Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy. | Clin Genitourin Cancer | 2022 | 35676169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=30